Nirmatrelvir and ritonavir combination against COVID‐19 caused by omicron BA. 2.2 in the elderly: A single‐center large observational study
C Chen, R Li, S Xing, L Cao, Y Qu, Q Lv… - Immunity …, 2024 - Wiley Online Library
Abstract Background Since coronavirus 2019 (COVID‐19) swept the world, a variety of novel
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
Nirmatrelvir and ritonavir combination against COVID‐19 caused by omicron BA. 2.2 in the elderly: A single‐center large observational study.
C Chen, R Li, S Xing, L Cao, Y Qu… - Immunity …, 2024 - search.ebscohost.com
Abstract Background: Since coronavirus 2019 (COVID‐19) swept the world, a variety of
novel therapeutic and prevention strategies have been developed, among which nirmatrelvir …
novel therapeutic and prevention strategies have been developed, among which nirmatrelvir …
[PDF][PDF] Nirmatrelvir and ritonavir combination against COVID‐19 caused by omicron BA. 2.2 in the elderly: A single‐center large observational study
C Chen, R Li, S Xing, L Cao, Y Qu, Q Lv, X Li, Z Chen - 2024 - scienceopen.com
Abstract Background: Since coronavirus 2019 (COVID‐19) swept the world, a variety of
novel therapeutic and prevention strategies have been developed, among which nirmatrelvir …
novel therapeutic and prevention strategies have been developed, among which nirmatrelvir …
[HTML][HTML] Nirmatrelvir and ritonavir combination against COVID‐19 caused by omicron BA. 2.2 in the elderly: A single‐center large observational study
C Chen, R Li, S Xing, L Cao, Y Qu, Q Lv… - Immunity, Inflammation …, 2024 - ncbi.nlm.nih.gov
Background Since coronavirus 2019 (COVID‐19) swept the world, a variety of novel
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
Nirmatrelvir and ritonavir combination against COVID-19 caused by omicron BA. 2.2 in the elderly: A single-center large observational study.
C Chen, R Li, S Xing, L Cao, Y Qu, Q Lv… - Immunity, Inflammation …, 2024 - europepmc.org
Background Since coronavirus 2019 (COVID-19) swept the world, a variety of novel
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
Nirmatrelvir and ritonavir combination against COVID-19 caused by omicron BA. 2.2 in the elderly: A single-center large observational study
C Chen, R Li, S Xing, L Cao, Y Qu… - Immunity …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Since coronavirus 2019 (COVID-19) swept the world, a variety of novel
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
therapeutic and prevention strategies have been developed, among which nirmatrelvir …
[引用][C] Nirmatrelvir and ritonavir combination against COVID‐19 caused by omicron BA. 2.2 in the elderly: A single‐center large observational study
C Chen, R Li, S Xing, L Cao, Y Qu, Q Lv, X Li, Z Chen - 2024 - europepmc.org
Abstract Background: Since coronavirus 2019 (COVID‐19) swept the world, a variety of
novel therapeutic and prevention strategies have been developed, among which nirmatrelvir …
novel therapeutic and prevention strategies have been developed, among which nirmatrelvir …